Alirocumab News
Alirocumab currently has 1 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Alirocumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Primary hypercholesterolaemia and mixed dyslipidaemia Praluent is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, and in...
- Evidence level: L5
- Predicted indications (20):
- ichthyosis, X-linked, without steroid sulfatase deficiency (99.4%)
- disorder of other vitamins and cofactors metabolism and transport (99.4%)
- xanthomatosis (disease) (99.4%)
- 46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect (99.4%)
- cholesterol catabolic process disease (99.4%)
- 46,XY disorder of sex development due to a cholesterol synthesis defect (99.3%)
- dappled diaphyseal dysplasia (99.3%)
- neutral lipid storage disease (99.3%)
- 3-hydroxyacyl-CoA dehydrogenase deficiency (99.3%)
- spastic paraplegia-optic atrophy-neuropathy and spastic paraplegia-optic atrophy-neuropathy-related disorder (99.3%)
- thrombocytopenic purpura (99.2%)
- chondrodysplasia punctata, brachytelephalangic, autosomal (99.2%)
- chondrodysplasia punctata, tibial-metacarpal type (99.2%)
- Astley-Kendall dysplasia (99.2%)
- spastic paraplegia (99.0%)
- adenosine deaminase deficiency (99.0%)
- syndromic dyslipidemia (98.8%)
- hemorrhagic disease of newborn (98.7%)
- familial apolipoprotein C-II deficiency (98.7%)
- severe combined immunodeficiency due to LCK deficiency (98.5%)
Related News (1)
‘I want to do everything I can to head off dementia’: why demand for the shingles vaccine is soaring - The Guardian
2026-10-11 dementia kidney failure
Source: The Guardian
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.